A Study Of Data Biorepository Utilizing MyDataHelps For Patients With And Without Cholestatic Liver Disease

Overview

About this study

The purpose of this study is to create a resource of data to better understand PBC, PSC, and controls from Mayo Clinic patients and non-Mayo Clinic Patients. Build a repository of information that can be utilized by other researchers. Build a data platform that will allow subjects to easily enter data about themselves, increase our interactions in patients, and help keep patients with PBC and PSC with the most up-to-date information with the CareEvolution platform using the MyDataHelps application.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion criteria

PSC

  • Patients between the ages of 18 and 85.

  • The diagnosis of PSC will be based on standard PSC criteria. 

  • Patients with PSC who have undergone liver transplantation will be offered enrollment.

  • Women with PSC of childbearing potential and pregnant women will be offered enrollment because there is no risk to an unborn child in this investigation.

PBC

  • Patients with PBC between the ages of 18 and 85.

  • The diagnosis of PBC will be based on standard PBC criteria. 

  • Patients with PBC who have undergone liver transplantation will be offered enrollment.

  • Women with PBC of childbearing potential and pregnant women will be offered enrollment because there is no risk to an unborn child in this investigation.

 

Non-PBC/PSC subjects (Controls)

  • Controls without history of PBC, PSC of either gender that will participate in this repository should be between the ages of 18-85. 

 

Exclusion criteria (all subjects)

  • Patients are unable to provide inform consent.

  • Prisoners and institutionalized individuals.

  • Patients who do not personally own a smartphone (iOS or Android)

  • Patients who are not willing/able to download, install or use the MyDataHelps applications

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/07/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Konstantinos Lazaridis, M.D.

Contact us for the latest status

Contact information:

Erik Schlicht

5072844312

schlicht.erik@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20598479

Mayo Clinic Footer